top of page
News, Events and Updates
Search
Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results
Feb 7, 2023
Anavex Life Sciences Reports Fiscal 2022 Year End Financial Results and Provides Business Update
Nov 28, 2022
Anavex Announces First Entire Clinical Alzheimer’s Gene Pathway Data of ANAVEX®2-73 at AAIC 2022
Jul 31, 2022
Anavex Life Sciences Announces Its Very First Scientific Educational Video News Release
Jun 20, 2022
Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study
Mar 15, 2022
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result
Aug 12, 2021
Anavex Life Sciences Announces ANAVEX®2-73 Improved both Primary Cognitive and Second MDS-UPDRS
Jun 27, 2021
Anavex Life Sciences Reports the Mechanism of ANAVEX®2-73 (blarcamesine) and ANAVEX®3-71 (AF710B)
Jun 13, 2021
Anavex Life Sciences Presents Proof of Concept Controlled Phase 2 Clinical Trial Data
Nov 6, 2020
Anavex Life Sciences Announces Positive Results from Proof of Concept controlled Phase 2 Trial
Oct 14, 2020
Anavex Life Sciences Announces Commitment for Financial Investment by Shake It Up Foundation
Aug 18, 2020
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
